These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 28218722)

  • 21. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
    Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
    Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammation (IL-1β) Modifies the Effect of Vitamin D and Omega-3 Long Chain Polyunsaturated Fatty Acids on Core Symptoms of Autism Spectrum Disorder-An Exploratory Pilot Study
    Mazahery H; Conlon CA; Beck KL; Mugridge O; Kruger MC; Stonehouse W; Camargo CA; Meyer BJ; Tsang B; von Hurst PR
    Nutrients; 2020 Feb; 12(3):. PubMed ID: 32121236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Docosahexaenoic acid in red blood cells of term infants receiving two levels of long-chain polyunsaturated fatty acids.
    Hoffman DR; Wheaton DK; James KJ; Tuazon M; Diersen-Schade DA; Harris CL; Stolz S; Berseth CL
    J Pediatr Gastroenterol Nutr; 2006 Mar; 42(3):287-92. PubMed ID: 16540798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlations between blood and tissue omega-3 LCPUFA status following dietary ALA intervention in rats.
    Tu WC; Mühlhäusler BS; Yelland LN; Gibson RA
    Prostaglandins Leukot Essent Fatty Acids; 2013 Jan; 88(1):53-60. PubMed ID: 22521090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomised controlled trial of vitamin D and omega-3 long chain polyunsaturated fatty acids in the treatment of irritability and hyperactivity among children with autism spectrum disorder.
    Mazahery H; Conlon CA; Beck KL; Mugridge O; Kruger MC; Stonehouse W; Camargo CA; Meyer BJ; Jones B; von Hurst PR
    J Steroid Biochem Mol Biol; 2019 Mar; 187():9-16. PubMed ID: 30744880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baseline blood levels of omega-3 and depression remission: a secondary analysis of data from a placebo-controlled trial of omega-3 supplements.
    Carney RM; Steinmeyer BC; Freedland KE; Rubin EH; Rich MW; Harris WS
    J Clin Psychiatry; 2016 Feb; 77(2):e138-43. PubMed ID: 26930527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-3 long-chain polyunsaturated fatty acids and risk of all-cause mortality among general populations: a meta-analysis.
    Chen GC; Yang J; Eggersdorfer M; Zhang W; Qin LQ
    Sci Rep; 2016 Jun; 6():28165. PubMed ID: 27306836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of supplementation of arachidonic acid (AA) or a combination of AA plus docosahexaenoic acid on breastmilk fatty acid composition.
    Smit EN; Koopmann M; Boersma ER; Muskiet FA
    Prostaglandins Leukot Essent Fatty Acids; 2000 Jun; 62(6):335-40. PubMed ID: 10913225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Omega-3 and Omega-6 Polyunsaturated Fatty Acid Levels and Correlations with Symptoms in Children with Attention Deficit Hyperactivity Disorder, Autistic Spectrum Disorder and Typically Developing Controls.
    Parletta N; Niyonsenga T; Duff J
    PLoS One; 2016; 11(5):e0156432. PubMed ID: 27232999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pilot study on the effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on body composition in children with acute lymphoblastic leukemia: randomized clinical trial.
    Barbosa-Cortés L; Martínez-Vieyra X; Mejía-Aranguré JM; López-Alarcón M; Martin-Trejo J; Delgadillo-Portillo S; Guzmán-Castro B; Delgadillo-Portillo J; Atilano-Miguel S; Rodríguez-Cruz M; Maldonado-Hernández J; Añoveros-Barrera A; Solís-Labastida KA; Espinoza-Hernández L; Nuñez-Villegas NN; Jiménez-Hernández E; Bautista-Martínez BA; Juárez-Moya A; Hernández-Piñón Z; Pérez-Casillas RX
    Clin Nutr; 2023 Sep; 42(9):1759-1769. PubMed ID: 37549598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The polyunsaturated fatty acid balance in kidney health and disease: A review.
    Syren ML; Turolo S; Marangoni F; Milani GP; Edefonti A; Montini G; Agostoni C
    Clin Nutr; 2018 Dec; 37(6 Pt A):1829-1839. PubMed ID: 29254659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of non-surgical periodontal treatment on serum levels of long chain-polyunsaturated fatty acids: a pilot randomized clinical trial.
    Martinez GL; Koury JC; Brito F; Fischer RG; Gustafsson A; Figueredo CM
    J Periodontal Res; 2014 Apr; 49(2):268-74. PubMed ID: 23721647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the influence of LCPUFA on neural development, aging, and neurodegeneration.
    Janssen CI; Kiliaan AJ
    Prog Lipid Res; 2014 Jan; 53():1-17. PubMed ID: 24334113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of n-3 long-chain polyunsaturated fatty acid intake during pregnancy on maternal, infant, and child health outcomes: a systematic review.
    Imhoff-Kunsch B; Briggs V; Goldenberg T; Ramakrishnan U
    Paediatr Perinat Epidemiol; 2012 Jul; 26 Suppl 1():91-107. PubMed ID: 22742604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Randomised-Controlled Trial of Vitamin D and Omega-3 Long Chain Polyunsaturated Fatty Acids in the Treatment of Core Symptoms of Autism Spectrum Disorder in Children.
    Mazahery H; Conlon CA; Beck KL; Mugridge O; Kruger MC; Stonehouse W; Camargo CA; Meyer BJ; Tsang B; Jones B; von Hurst PR
    J Autism Dev Disord; 2019 May; 49(5):1778-1794. PubMed ID: 30607782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methods of assessment of n-3 long-chain polyunsaturated fatty acid status in humans: a systematic review.
    Fekete K; Marosvölgyi T; Jakobik V; Decsi T
    Am J Clin Nutr; 2009 Jun; 89(6):2070S-2084S. PubMed ID: 19420097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of Nonalcoholic Fatty Liver Disease with Long-Chain n-3 Polyunsaturated Fatty Acids in Humans.
    Kelley NS
    Metab Syndr Relat Disord; 2016 Nov; 14(9):417-430. PubMed ID: 27710160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of 6 Weeks of n-3 fatty-acid supplementation on oxidative stress in Judo athletes.
    Filaire E; Massart A; Portier H; Rouveix M; Rosado F; Bage AS; Gobert M; Durand D
    Int J Sport Nutr Exerc Metab; 2010 Dec; 20(6):496-506. PubMed ID: 21116022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1.
    Berstad P; Seljeflot I; Veierød MB; Hjerkinn EM; Arnesen H; Pedersen JI
    Clin Sci (Lond); 2003 Jul; 105(1):13-20. PubMed ID: 12589702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Competitive Interaction Between Plasma Omega-3 Fatty Acids and Arachidonic Acid is Related to Down-Regulation of A Signaling Mediator.
    Yui K; Imataka G; Kawasaki Y
    Med Chem; 2016; 12(4):318-27. PubMed ID: 26740205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.